Literature DB >> 8297372

Functional coupling of human adenosine receptors to a ligand-dependent reporter gene system.

M J Castañón1, W Spevak.   

Abstract

We have stably transfected CHO cells that have integrated in their genome a reporter gene under the control of promoter sequences containing several copies of the cAMP response element, CRE, with different human adenosine receptors: A1, A2a and A2b. The new cell lines responded to the addition of known adenosine agonists and antagonists with changes in the expression of the reporter gene. The activity of the reporter gene can be easily monitored by bioluminescence. Although adenosine receptors are divergently coupled to adenylate cyclase, A1 receptors inhibit whereas A2 stimulate, changes in gene expression faithfully reflected the negative and positive coupling of the receptors. We have used the system to examine the pharmacological profile of the human receptors expressed in CHO cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297372     DOI: 10.1006/bbrc.1994.1091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Effects of a range of beta2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells.

Authors:  M G Scott; C Swan; T M Jobson; S Rees; I P Hall
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.

Authors:  M de Zwart; R Link; J K von Frijtag Drabbe Künzel; G Cristalli; K A Jacobson; A Townsend-Nicholson; A P IJzerman
Journal:  Nucleosides Nucleotides       Date:  1998-06

3.  Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures.

Authors:  A Francis; L Fochtmann
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.